Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Celltrion to List 57,364 Additional Common Shares Following Stock Option Exercise (068270)

Posted on November 8, 2024July 16, 2026 By K-STOCK Editor No Comments on [Disclosure] Celltrion to List 57,364 Additional Common Shares Following Stock Option Exercise (068270)

Source Facts: Financial Supervisory Service Electronic Disclosure System (DART) / 2024-11-08

Disclosure Type: Decision on Additional Listing (Exercise of Stock Options)

💡 3-Second Summary

Following the exercise of stock options, Celltrion will issue 57,364 new common shares, which are scheduled for additional listing on the Korea Exchange on November 13, 2024.

📊 1. [Key Disclosure Content & Major Financial Figures Summary]

  • Type and Number of Shares to be Listed: 57,364 registered common shares
  • Listing Date: November 13, 2024
  • Method of Capital Increase: Exercise of stock options (stock purchase options)
  • Date of Issue: October 24, 2024
  • Dividend Accrual Date: January 1, 2024 (Fiscal year-end: End of December)
  • Details of Stock Options Exercised by Round (Exercise Price & Quantity):
    • 142nd Round: KRW 52,697 (400 shares)
    • 143rd Round: KRW 86,161 (5,863 shares)
    • 144th Round: KRW 78,213 (12,951 shares)
    • 145th Round: KRW 169,828 (4,831 shares)
    • 146th Round: KRW 170,330 (3,879 shares)
    • 147th Round: KRW 49,499 (16,800 shares)
    • 148th Round: KRW 134,308 (9,140 shares)
    • 149th Round: KRW 140,017 (3,500 shares)
    • Par value per share is KRW 1,000.
  • Stock Codes: Standard Code: KR7068270008 (Ticker: A068270) / Industry Code: 03-21-01

📈 2. [Expert Perspective: What This Disclosure Means for Investors]

This regulatory filing outlines the administrative procedures for the listing of 57,364 new common shares, which were newly issued following the execution of stock options.

From a financial perspective, this transaction will increase the company’s total issued share count by 57,364 shares. The capital raised from this exercise is determined by multiplying the number of shares in each round (from the 142nd to the 149th) by their respective exercise prices, which range from KRW 49,499 to KRW 170,330. The date of issue was established on October 24, 2024. Because the dividend accrual date is set to January 1, 2024, these newly issued shares are eligible to receive year-end dividend payments for the 2024 fiscal year.

📝 Editor’s Comment (by K-STOCK Editor)

This fair disclosure registers the finalized listing schedule for 57,364 new common shares generated through stock option exercises. The transaction details are structured across multiple rounds, each with specific exercise prices and share quantities.

Investors should note that these newly listed shares will become active and eligible for open-market trading on the listing date of November 13, 2024. While this listing introduces additional shares into circulation, this specific filing does not provide details regarding lock-up periods or the immediate selling intentions of the option holders.

Consequently, the objective checkpoints for investors to monitor going forward are twofold: first, whether the 57,364 shares are listed on the Korea Exchange on the scheduled date of November 13, 2024; and second, the subsequent verification of the updated total issued share count in future periodic corporate reports. Tracking these administrative data points remains the necessary pathway to verifying when this capital increase process is completed.

📢 Disclaimer & Source Information

Source: This content has been structured and newly drafted based on official data submitted to the Financial Supervisory Service Electronic Disclosure System (DART).

Investment Risk Warning: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial liabilities rest solely with the investor.

Inquiries: For compliance inquiries or copyright-related requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] ISU PETASYS (007660) to Acquire KRW 42B Convertible Bonds of Carbon Nanotube Maker ‘JEIO’ to Accelerate Acquisition
Next Post: [Disclosure] Celltrion Reports Q3 2024 Preliminary Revenue of KRW 881.9B and Operating Profit of KRW 207.7B (068270)

Related Posts

[Disclosure] Celltrion (068270) Obtains South Korean Phase 3 Clinical Trial Approval for ‘CT-P13 SC’ (Remsima SC) in Pediatric Ulcerative Colitis Disclosures
[Disclosure] Hanwha Ocean (042660) to Hold Corporate Briefing (IR) for Q1 2026 Earnings Release on April 27 Disclosures
[Disclosure] SK hynix (000660) Clarifies Media Reports on US Advanced Packaging Fab: “Site Selection Under Review, But Nothing Confirmed Yet” Semiconductors
[Disclosure] Hanwha Ocean (042660) Formally Approves KRW 236.1B Debt-to-Equity Swap for Singapore Affiliate Disclosures
[Disclosure] Celltrion (068270) Obtains Final Approval for U.S. Blockbuster ‘Darzalex’ Biosimilar ‘CT-P44’ Phase 3 Clinical Trial in Europe (Part 2 Cleared) Disclosures
[Disclosure] Hanwha Ocean (042660) Formally Adjusts Disposal Value Upward to KRW 166.7B for Full Sale of Dyna-Mac Shares to Affiliate Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme